Trials / Withdrawn
WithdrawnNCT02838199
TRANscatheter or SurgIcal Aortic Valve ReplacemenT in All-Comers With Severe Aortic Valve Stenosis
Prospective, Open Label, Multicenter, Dual Arm, Randomized Trial of TRANscatheter or SurgIcal Aortic Valve ReplacemenT in All-Comers With Severe Aortic Valve Stenosis
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine that Transcatheter aortic valve replacement (TAVR) with SAPIEN 3 is superior to traditional surgical aortic valve replacement(SAVR) with bio-prosthesis regarding the rate of all-cause mortality at 1 year in patients with symptomatic severe aortic valve stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SAPIEN 3 | |
| PROCEDURE | SAVR |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2020-06-01
- Completion
- 2030-12-01
- First posted
- 2016-07-20
- Last updated
- 2016-11-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02838199. Inclusion in this directory is not an endorsement.